Illumina, Inc. (ILMN) Completes Acquisition of Verinata Health, Inc.
2/22/2013 10:09:50 AM
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced it has completed its previously announced acquisition of Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities. As of the close, Verinata Health became a wholly owned subsidiary of Illumina. “We look forward to working with the talented team at Verinata to quickly integrate our two companies,” said Jay T. Flatley, President and Chief Executive Officer of Illumina. “Verinata was founded with a mission to improve maternal and fetal health via the development of the verifi® prenatal test, a non-invasive prenatal test (NIPT) for high-risk pregnancies. As an innovator in the NIPT field, Verinata was the first provider to expand the test offering to include sex abnormalities. Bringing our two companies together provides a very strong collection of technologies and partners in the reproductive health market, with solutions that will lead to improved health outcomes.”